S100A9 and Miyoshi myopathy: A comparison of proteomic and drug sensitivity data from 35 MM patients also showed that the level of S100A8 and S100A9 proteins negatively correlated with bortezomib and panobinostat sensitivity (Figure 4C and Supplementary Table 7).